• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS TOTAL PSA, TOTAL (FREE + COMPLEXED) PSA - PROSTATE-SPECIFIC ANTIGEN (TPSA); TOTAL,PROSTATE SPECIFIC ANTIGEN(NONCOMPLEXED&COMPLEXED) FOR DETECTION OF PROS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS TOTAL PSA, TOTAL (FREE + COMPLEXED) PSA - PROSTATE-SPECIFIC ANTIGEN (TPSA); TOTAL,PROSTATE SPECIFIC ANTIGEN(NONCOMPLEXED&COMPLEXED) FOR DETECTION OF PROS Back to Search Results
Catalog Number ASKU
Device Problem Low Test Results (2458)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 04/15/2015
Event Type  malfunction  
Event Description
The customer received questionable free psa and total psa total (free + complexed) psa - prostate-specific antigen (total psa) results for one patient sample from cobas e601 analyzer serial number (b)(4).The specific date of testing was not provided.Refer to the medwatch with patient identifier (b)(6) for the free psa assay.The initial results were free psa 8.72 ng/ml and total psa 0.82 ng/ml.The repeat results were free psa 8.72 ng/ml and total psa 0.815 ng/ml.On (b)(6) 2015, the service personnel ran the sample a third time and the results were free psa 9.31 ng/ml and total psa 0.80 ng/ml.As the customer had another similar case, the customer sent the sample to be tested on an abbott and siemens centaur analyzer.Both of the results were a total psa greater than the free psa result.No specific data was provided.The laboratory's results and the results from the centaur were reported to their customer.Information concerning if the patient was adversely affected was requested, but was not provided.No action was taken based on the customer's results.As the sample could not be provided for further investigation, a specific root cause could not be determined.As the results for both assays were reproducible, interference in the sample was possible.Based on the provided calibration and qc data, a general reagent or system issue was not indicated.
 
Manufacturer Narrative
This event occurred in (b)(6).Unique identifier (udi)#: asku.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TOTAL PSA, TOTAL (FREE + COMPLEXED) PSA - PROSTATE-SPECIFIC ANTIGEN (TPSA)
Type of Device
TOTAL,PROSTATE SPECIFIC ANTIGEN(NONCOMPLEXED&COMPLEXED) FOR DETECTION OF PROS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 6830 5
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key4731551
MDR Text Key15320568
Report Number1823260-2015-03309
Device Sequence Number1
Product Code MTF
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
P990056
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Health Professional
Type of Report Initial
Report Date 04/27/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/27/2015
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberASKU
Device Lot NumberASKU
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Event Location Laboratory
Date Manufacturer Received04/16/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-